Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
9.11
+0.10 (1.11%)
Nov 13, 2026, 4:00 PM EST - Market closed

Core Laboratories Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
21.3822.719.1615.1215.4317.7
Cash & Short-Term Investments
21.3822.719.1615.1215.4317.7
Cash Growth
-16.59%18.50%26.70%-2.00%-12.85%28.23%
Accounts Receivable
115.57113.53111.76109.35106.9196.83
Other Receivables
11.447.2710.3213.728.199.91
Receivables
127.01120.8122.08123.07115.1106.74
Inventory
60.754.559.471.760.4545.44
Prepaid Expenses
10.219.7310.188.1515.6714.06
Other Current Assets
5.766.9410.525.095.065.11
Total Current Assets
225.06214.67221.33223.14211.7189.06
Property, Plant & Equipment
151.99153.79153.55153.47157.41172.34
Long-Term Investments
-4.435.084.844.454.16
Goodwill
105.92105.7999.4599.4599.4599.45
Other Intangible Assets
6.647.126.46.937.488.14
Long-Term Deferred Tax Assets
68.3567.3869.6169.268.5770.46
Other Long-Term Assets
35.5730.8429.7129.3829.337.26
Total Assets
593.52584.01585.13586.4578.35580.85

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
40.0137.2834.5533.5145.8529.73
Accrued Expenses
24.1930.830.0124.7328.2526.76
Current Portion of Leases
11.7211.4610.6910.1811.712.34
Current Income Taxes Payable
3.114.269.717.283.036.5
Current Unearned Revenue
5.845.559.334.765.947.77
Other Current Liabilities
17.8716.688.167.658.367.68
Total Current Liabilities
102.73106.02102.4588.1103.1490.78
Long-Term Debt
112.45110.26126.11163.13172.39194.08
Long-Term Leases
37.8142.3143.3442.0838.3149.29
Long-Term Unearned Revenue
----0.020.44
Pension & Post-Retirement Benefits
-1.371.722.272.684.09
Long-Term Deferred Tax Liabilities
10.1989.0712.722.8824.34
Other Long-Term Liabilities
46.2543.8650.1348.3149.9956.84
Total Liabilities
309.43311.8332.81356.59389.4419.85

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.470.470.470.471.191.19
Additional Paid-In Capital
116.65110.25109.55110.01102.25101.12
Retained Earnings
181.89172.66144.86120.7685.9568.35
Treasury Stock
-15.45-11.59-2.54-1.45-1.36-4.08
Comprehensive Income & Other
-5.59-5.81-5.77-4.97-3.78-10.13
Total Common Equity
277.97265.99246.57224.82184.26156.45
Minority Interest
6.126.225.754.994.74.55
Shareholders' Equity
284.09272.21252.32229.81188.95161
Total Liabilities & Equity
593.52584.01585.13586.4578.35580.85

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
161.97164.02180.14215.39222.39255.71
Net Cash (Debt)
-140.6-141.32-160.99-200.27-206.96-238.01
Net Cash Growth
------
Net Cash Per Share
-3.01-3.00-3.38-4.21-4.42-5.10
Filing Date Shares Outstanding
45.8246.0546.8346.8646.6346.28
Total Common Shares Outstanding
45.8146.146.8346.8646.6346.35
Working Capital
122.32108.65118.89135.04108.5798.27
Book Value Per Share
6.075.775.274.803.953.38
Tangible Book Value
165.41153.08140.73118.4477.3348.87
Tangible Book Value Per Share
3.613.323.012.531.661.05
Land
-10.4110.410.6510.6511.4
Buildings
-123.51117.68120.55120.99120.07
Machinery
-286.23283.3284.23288.12285.95
SEC Filings: 10-K · 10-Q